StreetInsider.com News Articles http://new.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Fri, 21 Aug 2026 16:30:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif StreetInsider.com News Articles http://new.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday Form 424B3 SAB Biotherapeutics, http://www.streetinsider.com/SEC+Filings/Form++424B3++++++SAB+Biotherapeutics%2C+++++++++++++++++/26961788.html si-local-file:///var/storage/secattach/20260821/26961788.html http://www.streetinsider.com/SEC+Filings/Form++424B3++++++SAB+Biotherapeutics%2C+++++++++++++++++/26961788.html Fri, 21 Aug 2026 16:30:00 -0400 O.49911890 SABS Form 424B3 SAB Biotherapeutics, http://www.streetinsider.com/SEC+Filings/Form++424B3++++++SAB+Biotherapeutics%2C+++++++++++++++++/26961788.html si-local-file:///var/storage/secattach/20260821/26961788.html http://www.streetinsider.com/SEC+Filings/Form++424B3++++++SAB+Biotherapeutics%2C+++++++++++++++++/26961788.html Fri, 21 Aug 2026 16:30:00 -0400 O.49911890 SABS Form SCHEDULE 13G/A SAB Biotherapeutics, Filed by: PERCEPTIVE ADVISORS LLC http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++SAB+Biotherapeutics%2C+++++++++++++++++++Filed+by%3A+PERCEPTIVE+ADVISORS+LLC/26932857.html si-local-file:///var/storage/secattach/20260814/26932857.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++SAB+Biotherapeutics%2C+++++++++++++++++++Filed+by%3A+PERCEPTIVE+ADVISORS+LLC/26932857.html Fri, 14 Aug 2026 17:24:00 -0400 O.49911890 SABS Form SCHEDULE 13G/A SAB Biotherapeutics, Filed by: PERCEPTIVE ADVISORS LLC http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++SAB+Biotherapeutics%2C+++++++++++++++++++Filed+by%3A+PERCEPTIVE+ADVISORS+LLC/26932857.html si-local-file:///var/storage/secattach/20260814/26932857.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++SAB+Biotherapeutics%2C+++++++++++++++++++Filed+by%3A+PERCEPTIVE+ADVISORS+LLC/26932857.html Fri, 14 Aug 2026 17:24:00 -0400 O.49911890 SABS Form SCHEDULE 13G/A SAB Biotherapeutics, Filed by: Caligan Partners LP http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++SAB+Biotherapeutics%2C+++++++++++++++++++Filed+by%3A+Caligan+Partners+LP/26932257.html si-local-file:///var/storage/secattach/20260814/26932257.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++SAB+Biotherapeutics%2C+++++++++++++++++++Filed+by%3A+Caligan+Partners+LP/26932257.html Fri, 14 Aug 2026 16:53:00 -0400 O.49911890 SABS Form SCHEDULE 13G/A SAB Biotherapeutics, Filed by: Caligan Partners LP http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++SAB+Biotherapeutics%2C+++++++++++++++++++Filed+by%3A+Caligan+Partners+LP/26932257.html si-local-file:///var/storage/secattach/20260814/26932257.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++SAB+Biotherapeutics%2C+++++++++++++++++++Filed+by%3A+Caligan+Partners+LP/26932257.html Fri, 14 Aug 2026 16:53:00 -0400 O.49911890 SABS Form SCHEDULE 13G/A SAB Biotherapeutics, Filed by: Commodore Capital LP http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++SAB+Biotherapeutics%2C+++++++++++++++++++Filed+by%3A+Commodore+Capital+LP/26930485.html si-local-file:///var/storage/secattach/20260814/26930485.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++SAB+Biotherapeutics%2C+++++++++++++++++++Filed+by%3A+Commodore+Capital+LP/26930485.html Fri, 14 Aug 2026 16:14:00 -0400 O.49911890 SABS Form SCHEDULE 13G/A SAB Biotherapeutics, Filed by: Commodore Capital LP http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++SAB+Biotherapeutics%2C+++++++++++++++++++Filed+by%3A+Commodore+Capital+LP/26930485.html si-local-file:///var/storage/secattach/20260814/26930485.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++SAB+Biotherapeutics%2C+++++++++++++++++++Filed+by%3A+Commodore+Capital+LP/26930485.html Fri, 14 Aug 2026 16:14:00 -0400 O.49911890 SABS Form SCHEDULE 13G/A SAB Biotherapeutics, Filed by: Vivo Opportunity Fund Holdings, L.P. http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++SAB+Biotherapeutics%2C+++++++++++++++++++Filed+by%3A+Vivo+Opportunity+Fund+Holdings%2C+L.P./26930464.html si-local-file:///var/storage/secattach/20260814/26930464.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++SAB+Biotherapeutics%2C+++++++++++++++++++Filed+by%3A+Vivo+Opportunity+Fund+Holdings%2C+L.P./26930464.html Fri, 14 Aug 2026 16:13:00 -0400 O.49911890 SABS Form SCHEDULE 13G/A SAB Biotherapeutics, Filed by: Vivo Opportunity Fund Holdings, L.P. http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++SAB+Biotherapeutics%2C+++++++++++++++++++Filed+by%3A+Vivo+Opportunity+Fund+Holdings%2C+L.P./26930464.html si-local-file:///var/storage/secattach/20260814/26930464.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++SAB+Biotherapeutics%2C+++++++++++++++++++Filed+by%3A+Vivo+Opportunity+Fund+Holdings%2C+L.P./26930464.html Fri, 14 Aug 2026 16:13:00 -0400 O.49911890 SABS Form SCHEDULE 13G/A SAB Biotherapeutics, Filed by: Woodline Partners LP http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++SAB+Biotherapeutics%2C+++++++++++++++++++Filed+by%3A+Woodline+Partners+LP/26927039.html si-local-file:///var/storage/secattach/20260814/26927039.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++SAB+Biotherapeutics%2C+++++++++++++++++++Filed+by%3A+Woodline+Partners+LP/26927039.html Fri, 14 Aug 2026 11:04:00 -0400 O.49911890 SABS Form SCHEDULE 13G/A SAB Biotherapeutics, Filed by: Woodline Partners LP http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++SAB+Biotherapeutics%2C+++++++++++++++++++Filed+by%3A+Woodline+Partners+LP/26927039.html si-local-file:///var/storage/secattach/20260814/26927039.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++SAB+Biotherapeutics%2C+++++++++++++++++++Filed+by%3A+Woodline+Partners+LP/26927039.html Fri, 14 Aug 2026 11:04:00 -0400 O.49911890 SABS Form SCHEDULE 13G/A SAB Biotherapeutics, Filed by: BALYASNY ASSET MANAGEMENT L.P. http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++SAB+Biotherapeutics%2C+++++++++++++++++++Filed+by%3A+BALYASNY+ASSET+MANAGEMENT+L.P./26924142.html si-local-file:///var/storage/secattach/20260814/26924142.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++SAB+Biotherapeutics%2C+++++++++++++++++++Filed+by%3A+BALYASNY+ASSET+MANAGEMENT+L.P./26924142.html Fri, 14 Aug 2026 06:10:00 -0400 O.49911890 SABS Form SCHEDULE 13G/A SAB Biotherapeutics, Filed by: BALYASNY ASSET MANAGEMENT L.P. http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++SAB+Biotherapeutics%2C+++++++++++++++++++Filed+by%3A+BALYASNY+ASSET+MANAGEMENT+L.P./26924142.html si-local-file:///var/storage/secattach/20260814/26924142.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++SAB+Biotherapeutics%2C+++++++++++++++++++Filed+by%3A+BALYASNY+ASSET+MANAGEMENT+L.P./26924142.html Fri, 14 Aug 2026 06:10:00 -0400 O.49911890 SABS Form SCHEDULE 13G SAB Biotherapeutics, Filed by: Adage Capital Management, L.P. http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++SAB+Biotherapeutics%2C+++++++++++++++++++Filed+by%3A+Adage+Capital+Management%2C+L.P./26911265.html si-local-file:///var/storage/secattach/20260812/26911265.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++SAB+Biotherapeutics%2C+++++++++++++++++++Filed+by%3A+Adage+Capital+Management%2C+L.P./26911265.html Wed, 12 Aug 2026 12:09:00 -0400 O.49911890 SABS Form SCHEDULE 13G SAB Biotherapeutics, Filed by: Adage Capital Management, L.P. http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++SAB+Biotherapeutics%2C+++++++++++++++++++Filed+by%3A+Adage+Capital+Management%2C+L.P./26911265.html si-local-file:///var/storage/secattach/20260812/26911265.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++SAB+Biotherapeutics%2C+++++++++++++++++++Filed+by%3A+Adage+Capital+Management%2C+L.P./26911265.html Wed, 12 Aug 2026 12:09:00 -0400 O.49911890 SABS Form SCHEDULE 13D/A SAB Biotherapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P. http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++SAB+Biotherapeutics%2C+++++++++++++++++++Filed+by%3A+RA+CAPITAL+MANAGEMENT%2C+L.P./26898383.html si-local-file:///var/storage/secattach/20260810/26898383.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++SAB+Biotherapeutics%2C+++++++++++++++++++Filed+by%3A+RA+CAPITAL+MANAGEMENT%2C+L.P./26898383.html Mon, 10 Aug 2026 16:27:00 -0400 O.49911890 SABS Form SCHEDULE 13D/A SAB Biotherapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P. http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++SAB+Biotherapeutics%2C+++++++++++++++++++Filed+by%3A+RA+CAPITAL+MANAGEMENT%2C+L.P./26898383.html si-local-file:///var/storage/secattach/20260810/26898383.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++SAB+Biotherapeutics%2C+++++++++++++++++++Filed+by%3A+RA+CAPITAL+MANAGEMENT%2C+L.P./26898383.html Mon, 10 Aug 2026 16:27:00 -0400 O.49911890 SABS Form 10-Q SAB Biotherapeutics, For: Jun 30 http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++SAB+Biotherapeutics%2C++++++For%3A+Jun+30/26879045.html si-local-file:///var/storage/secattach/20260806/26879045.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++SAB+Biotherapeutics%2C++++++For%3A+Jun+30/26879045.html Thu, 06 Aug 2026 07:57:00 -0400 O.49911890 SABS Form 10-Q SAB Biotherapeutics, For: Jun 30 http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++SAB+Biotherapeutics%2C++++++For%3A+Jun+30/26879045.html si-local-file:///var/storage/secattach/20260806/26879045.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++SAB+Biotherapeutics%2C++++++For%3A+Jun+30/26879045.html Thu, 06 Aug 2026 07:57:00 -0400 O.49911890 SABS Form 8-K SAB Biotherapeutics, For: Jul 07 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++SAB+Biotherapeutics%2C++++++For%3A+Jul+07/26739031.html si-local-file:///var/storage/secattach/20260707/26739031.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++SAB+Biotherapeutics%2C++++++For%3A+Jul+07/26739031.html Tue, 07 Jul 2026 08:15:00 -0400 O.49911890 SABS Form 8-K SAB Biotherapeutics, For: Jul 07 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++SAB+Biotherapeutics%2C++++++For%3A+Jul+07/26739031.html si-local-file:///var/storage/secattach/20260707/26739031.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++SAB+Biotherapeutics%2C++++++For%3A+Jul+07/26739031.html Tue, 07 Jul 2026 08:15:00 -0400 O.49911890 SABS Form 4 SAB Biotherapeutics, For: Jun 25 Filed by: Kropotova Alexandra http://www.streetinsider.com/SEC+Filings/Form++4++++++++++SAB+Biotherapeutics%2C++++++For%3A+Jun+25++Filed+by%3A+Kropotova+Alexandra/26699974.html si-local-file:///var/storage/secattach/20260626/26699974.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++SAB+Biotherapeutics%2C++++++For%3A+Jun+25++Filed+by%3A+Kropotova+Alexandra/26699974.html Fri, 26 Jun 2026 17:20:00 -0400 O.49911890 SABS Form 4 SAB Biotherapeutics, For: Jun 25 Filed by: Kropotova Alexandra http://www.streetinsider.com/SEC+Filings/Form++4++++++++++SAB+Biotherapeutics%2C++++++For%3A+Jun+25++Filed+by%3A+Kropotova+Alexandra/26699974.html si-local-file:///var/storage/secattach/20260626/26699974.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++SAB+Biotherapeutics%2C++++++For%3A+Jun+25++Filed+by%3A+Kropotova+Alexandra/26699974.html Fri, 26 Jun 2026 17:20:00 -0400 O.49911890 SABS Barclays Starts SAB Biotherapeutics (SABS) at Overweight http://www.streetinsider.com/New+Coverage/Barclays+Starts+SAB+Biotherapeutics+%28SABS%29+at+Overweight/26681853.html (Updated - June 24, 2026 6:20 AM EDT) <p>Barclays analyst Eliana Merle initiates coverage on SAB Biotherapeutics (NASDAQ: SABS) with a Overweight rating and a price target of $13.00.</p><p>The analyst commented: "Initiate coverage at Overweight with a PT of $13. We think at ~$300M market cap, the share price under-appreciates the ~$4B+ potential opportunity we see for SAB-142 as a therapy for T1D prevention; pivotal data in 2H27 with validated regulatory pathway using C-peptide biomarker. SABS is a smid cap biotech company with a platform technology for producing humanized multi-target antibody therapies, and lead candidate SAB-142 is in development for type http://www.streetinsider.com/New+Coverage/Barclays+Starts+SAB+Biotherapeutics+%28SABS%29+at+Overweight/26681853.html Wed, 24 Jun 2026 06:20:55 -0400 SABS